Noradrenergic terminals are the primary source of α

Adrenergic Neurons / drug effects Adrenergic alpha-2 Receptor Agonists / pharmacology Adrenergic alpha-2 Receptor Antagonists / pharmacology Animals Dopamine / metabolism Fluoxetine / analogs & derivatives Imidazoles / pharmacology Male Norepinephrine / metabolism Norepinephrine Plasma Membrane Transport Proteins / antagonists & inhibitors Prefrontal Cortex / drug effects Rats, Sprague-Dawley Receptors, Adrenergic, alpha-2 / metabolism
Anti-DBH-saporin Co-release D(2)-antagonist Microdialysis Norepinephrine transporter

Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
02 03 2019
Historique:
received: 23 07 2018
revised: 20 11 2018
accepted: 21 11 2018
pubmed: 26 11 2018
medline: 23 4 2019
entrez: 26 11 2018
Statut: ppublish

Résumé

In various psychiatric disorders, deficits in dopaminergic activity in the prefrontal cortex (PFC) are implicated. Treatments involving selective augmentation of dopaminergic activity in the PFC primarily depend on the inhibition of α

Identifiants

DOI: 10.1016/j.pnpbp.2018.11.015 PMID: 30472147
pubmed: 30472147
pii: S0278-5846(18)30564-5
doi: 10.1016/j.pnpbp.2018.11.015
pii:
doi:

Substances chimiques

Adrenergic alpha-2 Receptor Agonists 0
Adrenergic alpha-2 Receptor Antagonists 0
Imidazoles 0
Norepinephrine Plasma Membrane Transport Proteins 0
Receptors, Adrenergic, alpha-2 0
Fluoxetine 01K63SUP8D
atipamezole 03N9U5JAF6
nisoxetine 17NV064B2D
Dopamine VTD58H1Z2X
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-103

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Paola Devoto (P)

Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; Guy Everett Laboratory, University of Cagliari, Cagliari, Italy; National Institute of Neuroscience, INN, Section of Cagliari, Italy. Electronic address: pdevoto@unica.it.

Giovanna Flore (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Pierluigi Saba (P)

Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.

Simona Scheggi (S)

Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

Giovanna Mulas (G)

Dept. of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.

Carla Gambarana (C)

Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

Saturnino Spiga (S)

Dept. of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.

Gian Luigi Gessa (GL)

Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; Guy Everett Laboratory, University of Cagliari, Cagliari, Italy; National Research Council, CNR, Institute of Neuroscience, Cagliari, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Cellules › Neurones › Neurones adrénergiques › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents adrénergiques › Agonistes adrénergiques › Agonistes alpha-adrénergiques › Agonistes des récepteurs alpha-2 adrénergiques › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents adrénergiques › Antagonistes adrénergiques › Antagonistes alpha-adrénergiques › Antagonistes des récepteurs alpha-2 adrénergiques › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Eucaryotes › Animaux › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Catéchols › Catécholamines › Dopamine › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Composés chimiques organiques › Amines › Propylamines › Fluoxétine › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Catéchols › Catécholamines › Norépinéphrine › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Protéines transporteurs de solutés › Transporteurs de la norépinéphrine › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Télencéphale › Cerveau › Cortex cérébral › Lobe frontal › Cortex préfrontal › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Rat Sprague-Dawley › Noradrenergic terminals are the primary source of α
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs catécholaminergiques › Récepteurs adrénergiques › Récepteurs alpha-adrénergiques › Récepteurs alpha-2 adrénergiques › Noradrenergic terminals are the primary source of α